Skip to content

Author

M. Gynnild

We have 2 of 28 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Relationship between Lipoprotein(a) and subsequent cardiovascular events in patients with different locations of established cardiovascular disease

Lipoprotein(a) [Lp(a)] has been widely recognized as an independent causal risk factor for first cardiovascular events. However, the evidence in the setting of secondary prevention remains inconsistent, particularly across patients with different types of baseline atherosclerotic cardiovascular disease (ASCVD)....

J. Ebbers, E. Haug, M. Gynnild et al. · 0 citations
Aug 2026

Baseline and early changes in cardiac biomarkers as predictors of global longitudinal strain deterioration during breast cancer therapy: a PRADAII substudy

Baseline biomarker levels were not associated with GLS deterioration, and no biomarker–treatment interactions were observed (all p for interaction >0.27).Early post-anthracycline changes in hs-cTnI, hs-cTnT, or NT-proBNP were not predictive of subsequent GLS decline, nor were peak or persistent elevations (Table 1, Fig...

M. Gynnild, G. Gulati, A. Mecinaj-Lilleaasen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.